0001437749-24-017719.txt : 20240520
0001437749-24-017719.hdr.sgml : 20240520
20240520190038
ACCESSION NUMBER: 0001437749-24-017719
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240520
FILED AS OF DATE: 20240520
DATE AS OF CHANGE: 20240520
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ignelzi Troy A.
CENTRAL INDEX KEY: 0001579829
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-42001
FILM NUMBER: 24966459
MAIL ADDRESS:
STREET 1: C/O ESPERION THERAPEUTICS, INC.
STREET 2: 46701 COMMERCE CENTER DRIVE
CITY: PLYMOUTH
STATE: MI
ZIP: 48170
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Contineum Therapeutics, Inc.
CENTRAL INDEX KEY: 0001855175
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 271467257
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (858) 333-5280
MAIL ADDRESS:
STREET 1: 10578 SCIENCE CENTER DRIVE, SUITE 200
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Pipeline Therapeutics, Inc.
DATE OF NAME CHANGE: 20210405
4
1
rdgdoc.xml
FORM 4
X0508
4
2024-05-20
0001855175
Contineum Therapeutics, Inc.
CTNM
0001579829
Ignelzi Troy A.
10578 SCIENCE CENTER DRIVE, SUITE 200
SAN DIEGO
CA
92121
1
0
Stock Option (right to buy)
15.71
2024-05-20
4
A
0
23150
0
A
2034-05-19
Class A Common Stock
23150
23150
D
Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Plan. One-third of the option shares vest and become exercisable on May 20, 2025, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service.
/s/ Peter Slover, Attorney-in-Fact
2024-05-20